Literature DB >> 2198000

Pathogenicity of the enterococcus in surgical infections.

P S Barie1, N V Christou, E P Dellinger, W R Rout, H H Stone, J P Waymack.   

Abstract

The enterococcus has been relegated to a position of unimportance in the pathogenesis of surgical infections. However the increasing prevalence and virulence of these bacteria prompt reconsideration of this view, particularly because the surgical patient has become increasingly vulnerable to infectious morbidity due to debility, immunosuppression, and therapy with increasingly potent antibiotics. The enterococcus is a versatile opportunistic nosocomial pathogen, causing such diverse infections as wound, intra-abdominal, and urinary tract infections; catheter-associated infection; suppurative thrombophlebitis; endocarditis; and pneumonia. Although surgical drainage remains the cornerstone of therapy for enterococcal infections involving a discrete focus, in the circumstances typified by the compromised surgical patient, specific antibacterial therapy directed against the enterococcus is warranted. Recent evidence indicates that parenteral antibiotic therapy for enterococcal bacteremia is mandatory and that appropriate therapy clearly reduces the number of deaths.

Entities:  

Mesh:

Year:  1990        PMID: 2198000      PMCID: PMC1358050          DOI: 10.1097/00000658-199008000-00007

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  66 in total

1.  Nosocomial infection by gentamicin-resistant Streptococcus faecalis. An epidemiologic study.

Authors:  M J Zervos; C A Kauffman; P M Therasse; A G Bergman; T S Mikesell; D R Schaberg
Journal:  Ann Intern Med       Date:  1987-05       Impact factor: 25.391

Review 2.  The enterococcus.

Authors:  R M Gullberg
Journal:  Infect Control       Date:  1986-12

3.  Suppurative thrombophlebitis: correlation between pathogen and underlying disease.

Authors:  R A Johnson; R A Zajac; M E Evans
Journal:  Infect Control       Date:  1986-12

4.  Comparison of two beta-lactamase-producing strains of Streptococcus faecalis.

Authors:  B E Murray; D A Church; A Wanger; K Zscheck; M E Levison; M J Ingerman; E Abrutyn; B Mederski-Samoraj
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

5.  Susceptibility and bactericidal activity studies of four beta-lactamase-producing enterococci.

Authors:  J E Patterson; M J Zervos
Journal:  Antimicrob Agents Chemother       Date:  1989-02       Impact factor: 5.191

6.  Vancomycin-resistant enterococci.

Authors:  A H Uttley; C H Collins; J Naidoo; R C George
Journal:  Lancet       Date:  1988 Jan 2-9       Impact factor: 79.321

Review 7.  The enterococcus: "putting the bug in our ears".

Authors:  S A Hoffmann; R C Moellering
Journal:  Ann Intern Med       Date:  1987-05       Impact factor: 25.391

8.  Identification of Streptococcus faecalis and Streptococcus faecium and susceptibility studies with newly developed antimicrobial agents.

Authors:  M J Kim; M Weiser; S Gottschall; E L Randall
Journal:  J Clin Microbiol       Date:  1987-05       Impact factor: 5.948

9.  Effects of clindamycin and metronidazole on the intestinal colonization and translocation of enterococci in mice.

Authors:  C L Wells; R P Jechorek; M A Maddaus; R L Simmons
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

10.  Role of anaerobic flora in the translocation of aerobic and facultatively anaerobic intestinal bacteria.

Authors:  C L Wells; M A Maddaus; C M Reynolds; R P Jechorek; R L Simmons
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

View more
  13 in total

1.  Enterococcal bactibilia in patients with malignant biliary obstruction.

Authors:  T Nomura; Y Shirai; K Hatakeyama
Journal:  Dig Dis Sci       Date:  2000-11       Impact factor: 3.199

2.  Perioperative antibiotics covering bile contamination prevent abdominal infectious complications after pancreatoduodenectomy in patients with preoperative biliary drainage.

Authors:  Takeshi Sudo; Yoshiaki Murakami; Kenichiro Uemura; Yasushi Hashimoto; Naru Kondo; Naoya Nakagawa; Hiroki Ohge; Taijiro Sueda
Journal:  World J Surg       Date:  2014-11       Impact factor: 3.352

3.  Disparate findings on the role of virulence factors of Enterococcus faecalis in mouse and rat models of peritonitis.

Authors:  H Dupont; P Montravers; J Mohler; C Carbon
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

4.  Results of a clinical trial of clinafloxacin versus imipenem/cilastatin for intraabdominal infections.

Authors:  J S Solomkin; S E Wilson; N V Christou; O D Rotstein; E P Dellinger; R S Bennion; R Pak; K Tack
Journal:  Ann Surg       Date:  2001-01       Impact factor: 12.969

Review 5.  Critical issues in the clinical management of complicated intra-abdominal infections.

Authors:  Stijn Blot; Jan J De Waele
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 6.  Current concepts in peritonitis.

Authors:  Mark A Malangoni
Journal:  Curr Gastroenterol Rep       Date:  2003-08

Review 7.  Are there patients with peritonitis who require empiric therapy for enterococcus?

Authors:  S Harbarth; I Uckay
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-01-21       Impact factor: 3.267

Review 8.  Multidrug-resistant enterococci: the dawn of a new era in resistant pathogens.

Authors:  S J Antony
Journal:  J Natl Med Assoc       Date:  1998-09       Impact factor: 1.798

9.  Enterococcus: not an innocent bystander in cirrhotic patients with spontaneous bacterial peritonitis.

Authors:  J-H Lee; J-H Yoon; B H Kim; G E Chung; S J Myung; W Kim; Y J Kim; E-C Kim; H-S Lee
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-07-09       Impact factor: 3.267

10.  Results of a randomized trial comparing sequential intravenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intra-abdominal infections. The Intra-Abdominal Infection Study Group.

Authors:  J S Solomkin; H H Reinhart; E P Dellinger; J M Bohnen; O D Rotstein; S B Vogel; H H Simms; C S Hill; H S Bjornson; D C Haverstock; H O Coulter; R M Echols
Journal:  Ann Surg       Date:  1996-03       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.